This company is no longer actively trading as an independent public company (delisted, acquired, or ceased operations). This profile is retained for reference.
HAVN Life is a part of a global community taking an active part in supporting research for microdosing therapies in treating mental health disorders utilizing psychedelics. Working with Veterans and thought leaders in the military, HAVN Life is developing innovative formulations to support clinical trials addressing PTSD recovery and other trauma related disorders.
Stock Performance
Havn Life Sciences Inc. News 18 articles
- HAVN Life Announces Retail Listing With Loblaws Company Ltd
- What Does the Future of Psychedelics Look Like?: A Mindshifting Moments Special Event
- HAVN Life Provides Corporate Update
- HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments and the Issuance of Shares for Debt
- HAVN Life Announces Financing Commitment of C$9,000,000 through the issuance of Convertible Debentures and Warrants
- HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.
- HAVN Life Sciences Health Products Listed On Amazon
- HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research
- HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market
- HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.
- HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations
- HAVN Life to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
- Havn Life Sciences: Supplying the Compounds to Support the Future of Psychedelic Medicine
- Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds
- Havn Life Sciences submits range of natural health products to Health Canada
- Havn Life Sciences granted Section 56 exemption to begin scientific work with psilocybin
- Psychedelics Company Havn Life Announces Commencement of Public Trading on the CSE
- Havn Life Sciences Announces Filing of Final Prospectus and Conditional Approval for Listing on CSE